- Filed
- May 10, 2019 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2019 · Mar 31, 2019 | 403.7M sh |
| Shares Diluted | Q2 2019 · Mar 31, 2019 | 403.6M sh |
| Shares Diluted | Q2 2019 · Mar 31, 2018 | 402.9M sh |
| Shares Diluted | Q2 2019 · Mar 31, 2018 | 402.7M sh |
| Dividends Paid | Q2 2019 · Mar 31, 2019 | $161M |
| Dividends Paid | Q2 2019 · Mar 31, 2018 | $161M |
| Capex | Q2 2019 · Mar 31, 2019 | $77M |
| Capex | Q2 2019 · Mar 31, 2018 | $64M |
| Operating Cash Flow | Q2 2019 · Mar 31, 2019 | $719M |
| Operating Cash Flow | Q2 2019 · Mar 31, 2018 | $299M |
| Long Term Debt | Q2 2019 · Mar 31, 2019 | $8.96B |
| Long Term Debt | Q2 2019 · Sep 30, 2018 | $10.08B |
| Short Term Debt | Q2 2019 · Mar 31, 2019 | $322M |
| Short Term Debt | Q2 2019 · Sep 30, 2018 | $567M |
| Cash And Equivalents | Q2 2019 · Mar 31, 2019 | $486M |
| Cash And Equivalents | Q2 2019 · Sep 30, 2018 | $1.56B |
| Cash And Equivalents | Q2 2019 · Mar 31, 2018 | $417M |
| Cash And Equivalents | Q2 2019 · Sep 30, 2017 | $1.39B |
| Stockholders Equity | Q2 2019 · Mar 31, 2019 | $7.98B |
| Stockholders Equity | Q2 2019 · Sep 30, 2018 | $7.41B |
| Current Liabilities | Q2 2019 · Mar 31, 2019 | $3.87B |
| Current Liabilities | Q2 2019 · Sep 30, 2018 | $4.05B |
| Current Assets | Q2 2019 · Mar 31, 2019 | $5B |
| Current Assets | Q2 2019 · Sep 30, 2018 | $6.08B |
| Total Assets | Q2 2019 · Mar 31, 2019 | $23.09B |
| Total Assets | Q2 2019 · Sep 30, 2018 | $23.78B |
| Eps Diluted | Q2 2019 · Mar 31, 2019 | $0.93 |
| Eps Diluted | Q2 2019 · Mar 31, 2019 | $1.73 |
| Eps Diluted | Q2 2019 · Mar 31, 2018 | $0.66 |
| Eps Diluted | Q2 2019 · Mar 31, 2018 | $1.99 |
| Eps Basic | Q2 2019 · Mar 31, 2019 | $0.93 |
| Eps Basic | Q2 2019 · Mar 31, 2019 | $1.73 |
| Eps Basic | Q2 2019 · Mar 31, 2018 | $0.66 |
| Eps Basic | Q2 2019 · Mar 31, 2018 | $2.00 |
| Sga Expense | Q2 2019 · Mar 31, 2019 | $743M |
| Sga Expense | Q2 2019 · Mar 31, 2019 | $1.43B |
| Sga Expense | Q2 2019 · Mar 31, 2018 | $771M |
| Sga Expense restated | Q2 2019 · Mar 31, 2018 | $1.51B |
| Net Income | Q2 2019 · Mar 31, 2019 | $376M |
| Net Income | Q2 2019 · Mar 31, 2019 | $697M |
| Net Income | Q2 2019 · Mar 31, 2018 | $266M |
| Net Income | Q2 2019 · Mar 31, 2018 | $803M |
| Operating Income | Q2 2019 · Mar 31, 2019 | $573M |
| Operating Income | Q2 2019 · Mar 31, 2019 | $1.18B |
| Operating Income | Q2 2019 · Mar 31, 2018 | $456M |
| Operating Income restated | Q2 2019 · Mar 31, 2018 | $1.17B |
| Cost Of Revenue | Q2 2019 · Mar 31, 2019 | $1.52B |
| Cost Of Revenue | Q2 2019 · Mar 31, 2019 | $3.21B |
| Cost Of Revenue | Q2 2019 · Mar 31, 2018 | $1.68B |
| Cost Of Revenue | Q2 2019 · Mar 31, 2018 | $3.24B |
| Revenue | Q2 2019 · Mar 31, 2019 | $2.96B |
| Revenue | Q2 2019 · Mar 31, 2019 | $6.05B |
| Revenue | Q2 2019 · Mar 31, 2018 | $3.15B |
| Revenue | Q2 2019 · Mar 31, 2018 | $6.22B |